Cirius Therapeutics, Inc. [Rocket]

In millions, except per share items	Dec-31-18	Dec-31-17	Dec-31-16
	S-1/A	S-1/A	S-1
Revenues	19.2	16.4	4.2
Revenue growth	17.5%	286.8%
Cost of goods sold	22.4	18.3	4.7
Gross profit	-3.2	-1.9	-0.5
Gross margin	-16.7%	-11.9%	-11.9%
Selling, general and administrative [+]	3.2	1.9	0.5
General and administrative	3.2	1.9	0.5
Other operating expenses	16.0	14.4	3.7
EBITDA [+]	-22.2	-18.2
EBITDA growth	21.7%	285.3%
EBITDA margin	-115.4%	-111.4%	-111.9%
Depreciation and amortization	0.2	0.1
EBIT [+]	-22.4	-18.3	-4.7
EBIT growth	22.5%	287.0%
EBIT margin	-116.7%	-111.9%	-111.9%
Interest income	0.2	0.2	0.0
Interest income	0.2	0.2	0.0
Other income (expense), net	22.3	18.1	4.7
Pre-tax income	0.0	0.0	0.0
Income taxes	0.0	0.0	0.0
Net income	0.0	0.0	0.0
Net margin	0.0%	0.0%	0.0%



EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.